Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • BI 638683 - Healthy
    Clinical Study Number 1279.1
    Study Indication Healthy
    Product BI 638683
    Generic Name BI 638683
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability, pharmacokinetics and pharmacodynamics of single rising oral doses (1-700 mg) of BI 638683 Powder in bottle (PiB) in healthy male volunteers (randomised, double-blind, placebo-controlled within dose groups)

    Study Document
    Trial synopsis 1279.1 english